Skip to content
healthcare.dev

phenoxybenzamine hydrochloride

NDC 16571-874, phenoxybenzamine hydrochloride, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-874
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204551
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-874 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENOXYBENZAMINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
16571-874-0116571087401100 CAPSULE in 1 BOTTLE (16571-874-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1d2108fa-4352-4f3f-9314-732ed8b6394c

Use it

Look up 16571-874 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-874 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-874. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.